Inspyr Therapeutics
$0.002700
2
-$0.00-18.18% Monday 21:58
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
1.39M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
22NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.04
0.03
0.09
0.16
Expected EPS
0
Actual EPS
0
Financials
-Profit Margin
Profitable0Revenue
2.7MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Pharmaceuticals: Other
Health Technology
Manufacturing
Pharmaceutical Preparation Manufacturing
Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
Show more...
CEO
Country
United States
ISIN
US75619J1034
Listings
0 Comments
Share your thoughts
FAQ
What is Inspyr Therapeutics stock price today?▼
The current price of NSPX is $0.00 USD — it has decreased by -18.18% in the past 24 hours. Watch Inspyr Therapeutics stock price performance more closely on the chart.
What is Inspyr Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on PINX exchange Inspyr Therapeutics stocks are traded under the ticker NSPX.
What is Inspyr Therapeutics market cap?▼
Today Inspyr Therapeutics has the market capitalization of 1.39M
What were Inspyr Therapeutics earnings last quarter?▼
NSPX earnings for the last quarter are 0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Inspyr Therapeutics revenue for the last year?▼
Inspyr Therapeutics revenue for the last year amounts to 0 USD.
What is Inspyr Therapeutics net income for the last year?▼
NSPX net income for the last year is 2.7M USD.
In which sector is Inspyr Therapeutics located?▼
Inspyr Therapeutics operates in the Manufacturing sector.
When did Inspyr Therapeutics complete a stock split?▼
The last stock split for Inspyr Therapeutics was on October 01, 2019 with a ratio of 1:25.
Where is Inspyr Therapeutics headquartered?▼
Inspyr Therapeutics is headquartered in Westlake Village, United States.